BackZhengye Biotechnology Holding Limited Overview

Zhengye Biotechnology Holding Limited Total Current Liabilities

Track Zhengye Biotechnology Holding Limited's total current liabilities ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$120.48M
↓ 11.35% YoYΔ $-15.43M vs prior year quarter

Peer trimmed avg / median

Loading

Zhengye Biotechnology Holding Limited Total Current Liabilities History

Loading

Zhengye Biotechnology Holding Limited vs. peers: Total Current Liabilities Comparison

Loading

Zhengye Biotechnology Holding Limited Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zhengye Biotechnology Holding Limited (ZYBT) FAQ

As of the most recent data (December 2025), ZYBT shows a total current liabilities of $120M. That compares with $140M in the prior-year period — down 11.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZYBT's total current liabilities is now $120M (was $140M) — a 11.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zhengye Biotechnology Holding Limited is outperforming or lagging.

Tracking ZYBT's total current liabilities over time shows whether Zhengye Biotechnology Holding Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $120M That compares with $140M in the prior-year period — down 11.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Zhengye Biotechnology Holding Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $120M) with ownership activity and broader fundamentals.